Market Report, "Peru Pharmaceuticals & Healthcare Report Q2 2016", published

In spite of its small market size and developing health care system , its promising economic outlook and its government's commitment to increased investment in the healthcare sector will be factors contributing to the improvement of Peru's pharmaceutical business environment. We believe that, over the next decade, drugmakers and medical device firms will enjoy revenue growth in the country, in the light of efforts to achieve greater health coverage and improved health indicators .

Headline Expenditure Projections

Pharmaceuticals: PEN4.98bn (USD1.57bn) in 2015 to PEN5.32bn (USD1.50bn) in 2016; +6.7% in local currency terms and -4.0% in US dollar terms.
Healthcare: PEN33.9bn (USD10.6bn) in 2015 to PEN36.8bn (USD10.4bn) in 2016; +8.5% in local currency terms and -2.4% in US dollar terms.

Risk/Reward Index

In BMI's Risk/Reward Index (RRI) for Q216, Peru has maintained its position as ninth out of the 19 markets surveyed in the Americas matrix. Peru's Reward scores are viewed as being less favourable than the regional averages, while its risk scores are slightly above average. A small market size and a deficient intellectual property environment are some of the major drawbacks to involvement in Peru by foreign companies. Nevertheless, Peru is still seen as being able to offer longer-term benefits to foreign investors, on account of the expected healthcare market development and economic growth.

Full Report Details at
- http://www.fastmr.com/prod/1152866_peru_pharmaceuticals.aspx?afid=301

Latest Updates

Hersil announced plans to expand in Latin America through the opening of commercial offices during a celebration to mark 50 years of its operation in November 2015. According to the General Manager, Jose Luis Silva Martinot, the first office will be opened in Ecuador and is hoped to be completed by the end of 2015. The company also plans to open two sales offices in Guatemala and Chile by 2017.

The first case of Zika was identified in Peru on January 29, in a person who had recently travelled to Venezuela. With the virus circulating widely in neighbouring countries, Health Minister Anibal Velasquez has described cases in Peru as 'inevitable'.

BMI Economic View

Over the next 10 years, Peru's economy will gradually develop new industries outside of the extractive sector. While the metals mining will remain an integral part of the economy, government policy will seek to support diversification through improvements to the country's infrastructure and public services. The country's expanding middle class will make private consumption an increasingly important growth driver. Compared to the export-led boom years of the last decade, Peru will see modestly lower average growth rates. That said, Peru is likely to remain among the region's best performing economies. After elevated commodities prices boosted average real GDP growth to 6.1% y-o-y between 2002 and 2013, we forecast average growth of 4.3% between 2016 and 2025.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)